EA201990850A1 - MODULATOR OF A FLOW-MOVICIDE TRANSMEMBRANE CONDUCTIVITY REGULATOR, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND METHODS OF PRODUCING A MODULATOR - Google Patents

MODULATOR OF A FLOW-MOVICIDE TRANSMEMBRANE CONDUCTIVITY REGULATOR, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND METHODS OF PRODUCING A MODULATOR

Info

Publication number
EA201990850A1
EA201990850A1 EA201990850A EA201990850A EA201990850A1 EA 201990850 A1 EA201990850 A1 EA 201990850A1 EA 201990850 A EA201990850 A EA 201990850A EA 201990850 A EA201990850 A EA 201990850A EA 201990850 A1 EA201990850 A1 EA 201990850A1
Authority
EA
Eurasian Patent Office
Prior art keywords
modulator
methods
pharmaceutical compositions
movicide
producing
Prior art date
Application number
EA201990850A
Other languages
Russian (ru)
Inventor
Тимоти Алкасио
Минсон Бейк
Петер ГРОТЕНХЕЙС
Сара Сабина Адида Руа
Роберт М. Хьюз
Али Кесхаварз-Схокри
Рейчел Маколи-Аоки
Джейсон Маккартни
Марк Томас Миллер
Фредрик Ван Гор
Бэйли Чжан
Кори Андерсон
Томас Кливленд
Брайан А. Фриман
Харипада Кхатуя
Прамод Вирупакс Джоши
Пол Джон Кренитски
Вито Мелилло
Фабрис Жан Денис Пьер
Андреас П. Термин
Джонни Ю
Цзинлань ЧЖОУ
Александр Расселл Абела
Бретт Брэдли Буш
Прасуна Параселли
Дэвид Эндрю Сисел
Original Assignee
Вертекс Фармасьютикалз Инкорпорейтед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вертекс Фармасьютикалз Инкорпорейтед filed Critical Вертекс Фармасьютикалз Инкорпорейтед
Priority claimed from PCT/US2017/054611 external-priority patent/WO2018064632A1/en
Publication of EA201990850A1 publication Critical patent/EA201990850A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Описаны соединения формулы (I)их фармацевтически приемлемые соли, их дейтерированные производные и их метаболиты. Также раскрыты фармацевтические композиции, содержащие их, способы лечения муковисцидоза с их применением, а также способы их получения.The compounds of formula (I), their pharmaceutically acceptable salts, their deuterated derivatives and their metabolites are described. Also disclosed are pharmaceutical compositions containing them, methods for treating cystic fibrosis with their use, as well as methods for their preparation.

EA201990850A 2016-11-09 2017-09-29 MODULATOR OF A FLOW-MOVICIDE TRANSMEMBRANE CONDUCTIVITY REGULATOR, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND METHODS OF PRODUCING A MODULATOR EA201990850A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662419935P 2016-11-09 2016-11-09
PCT/US2017/054611 WO2018064632A1 (en) 2016-09-30 2017-09-29 Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

Publications (1)

Publication Number Publication Date
EA201990850A1 true EA201990850A1 (en) 2019-09-30

Family

ID=68000208

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990850A EA201990850A1 (en) 2016-11-09 2017-09-29 MODULATOR OF A FLOW-MOVICIDE TRANSMEMBRANE CONDUCTIVITY REGULATOR, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND METHODS OF PRODUCING A MODULATOR

Country Status (1)

Country Link
EA (1) EA201990850A1 (en)

Similar Documents

Publication Publication Date Title
EA202091930A1 (en) MACROCYCLES AS MODULATORS OF A FLUISCIDAL TRANSMEMBRANE CONDUCTIVITY REGULATOR, THEIR PHARMACEUTICAL COMPOSITIONS, THEIR APPLICATION FOR THE TREATMENT OF FLUISCIDOSIS AND THE METHOD OF THEIR MANUFACTURE
EA201991403A1 (en) TRANSMEMBRANE CONDUCTIVITY REGULATOR MODULATOR FOR MUKOVISCIDOSIS, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND METHOD OF OBTAINING THE INDICATED MODULATOR
DOP2019000081A (en) MODULATOR OF THE CHEMICAL FIBROSIS TRANSMEMBRANE DRIVING REGULATOR, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND PROCESS TO PRODUCE THE MODULATOR
EA202192704A1 (en) DRUGS THAT MODULATE THE REGULATOR OF TRANSMEMBRANE CONDUCTIVITY IN CYSISTIC FIBRIOSIS
NZ768373A (en) Modulators of cystic fibrosis transmembrane conductance regulator
EA201891191A1 (en) 2-SUBSTITUTED HINAZOLIN COMPOUNDS CONTAINING A SUBSTITUTED HETEROCYCLIC GROUP AND METHODS OF THEIR APPLICATION
EA201692280A1 (en) CONNECTIONS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY
EA201490864A1 (en) DERIVATIVES (4-PHENYLIMIDAZOL-2-IL) ETYLAMINE AS SODIUM CHANNEL MODULATORS
EA201792594A1 (en) POSITIVE ALLOSTERIC MODULATORS OF MUSARIN M1 RECEPTOR
EA201890684A1 (en) FLUORINDOL DERIVATIVES AS A POSITIVE ALLOSTERIC MODULATORS OF MUSCARINE M1 RECEPTOR
EA201700356A1 (en) NEW CYCLOPROPANBENZOFURANILPYRIDOPYRAZINDIONS
EA201990850A1 (en) MODULATOR OF A FLOW-MOVICIDE TRANSMEMBRANE CONDUCTIVITY REGULATOR, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND METHODS OF PRODUCING A MODULATOR
CR20190211A (en) Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
EA201992719A1 (en) Deuterated pyridone amides and their prodrugs as sodium channel modulators
EA201992153A1 (en) Heteroaryl trifluoroborate compounds for the treatment of mycobacterial infections